Die rechtliche Zulässigkeit von Placebokontrollgruppen in Arzneimittelstudien
Clinical trials of medicinal products on human subjects are a balancing act between the protection of the study participant and the preservation of his dignity on the one hand and the constant striving for medical progress on the other hand. This applies likewise to the control group as an essential...
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Format: | Online |
| Jezik: | nemščina |
| Izdano: |
Universitätsverlag Göttingen
2021
|
| Teme: | |
| Online dostop: | OCN: 1091435474 |
| Oznake: |
Brez oznak, prvi označite!
|
| _version_ | 1869514240354680832 |
|---|---|
| author | Friske, Franziska B. |
| author_browse | Friske, Franziska B. |
| author_facet | Friske, Franziska B. |
| author_sort | Friske, Franziska B. |
| collection | Directory of Open Access Books |
| description | Clinical trials of medicinal products on human subjects are a balancing act between the protection of the study participant and the preservation of his dignity on the one hand and the constant striving for medical progress on the other hand. This applies likewise to the control group as an essential part of every clinical testing of pharmaceuticals without which no drug will receive marketing authorisation in Germany by the competent authorities. Nevertheless, significant gaps in the German legislation concerning this matter still remain as the German legislator has yet to implement any specific rules with regard to the handling and management of the control group in clinical trials. In view of this unsettled legal situation, the author critically analyses the core of the problem areas in this field’s current research practice and creates solutions reflecting the interests of the study participant as well as the practical needs of medical research. Only legal clarity regarding the control group can provide for the safety that is crucial in this field of tension between ethics, medicine and the law. |
| format | Online |
| id | doab-20.500.12854ir-34075 |
| institution | Directory of Open Access Books |
| language | ger |
| publishDate | 2021 |
| publishDateRange | 2021 |
| publishDateSort | 2021 |
| publisher | Universitätsverlag Göttingen |
| publisherStr | Universitätsverlag Göttingen |
| record_format | ojs |
| spelling | doab-20.500.12854ir-340752025-04-03T10:20:06Z Die rechtliche Zulässigkeit von Placebokontrollgruppen in Arzneimittelstudien Friske, Franziska B. thema EDItEUR::L Law Clinical trials of medicinal products on human subjects are a balancing act between the protection of the study participant and the preservation of his dignity on the one hand and the constant striving for medical progress on the other hand. This applies likewise to the control group as an essential part of every clinical testing of pharmaceuticals without which no drug will receive marketing authorisation in Germany by the competent authorities. Nevertheless, significant gaps in the German legislation concerning this matter still remain as the German legislator has yet to implement any specific rules with regard to the handling and management of the control group in clinical trials. In view of this unsettled legal situation, the author critically analyses the core of the problem areas in this field’s current research practice and creates solutions reflecting the interests of the study participant as well as the practical needs of medical research. Only legal clarity regarding the control group can provide for the safety that is crucial in this field of tension between ethics, medicine and the law. 2021-02-10T12:58:18Z 2020-04-15T02:45:07Z 2017 book book OCN: 1091435474 http://library.oapen.org/handle/20.500.12657/37162 https://directory.doabooks.org/handle/20.500.12854/34075 ger open access image/jpeg image/jpeg image/jpeg image/jpeg image/jpeg n/a n/a n/a n/a n/a https://library.oapen.org/bitstream/20.500.12657/37162/1/GSM24_friske.pdf https://library.oapen.org/bitstream/20.500.12657/37162/1/GSM24_friske.pdf https://library.oapen.org/bitstream/20.500.12657/37162/1/GSM24_friske.pdf https://library.oapen.org/bitstream/20.500.12657/37162/1/GSM24_friske.pdf https://library.oapen.org/bitstream/20.500.12657/37162/1/GSM24_friske.pdf Universitätsverlag Göttingen 10.17875/gup2017-1041 10.17875/gup2017-1041 af9011e0-03b9-4a5c-9ae6-b9da4898d1b2 AG Universitätsverlage open access |
| spellingShingle | thema EDItEUR::L Law Friske, Franziska B. Die rechtliche Zulässigkeit von Placebokontrollgruppen in Arzneimittelstudien |
| title | Die rechtliche Zulässigkeit von Placebokontrollgruppen in Arzneimittelstudien |
| title_full | Die rechtliche Zulässigkeit von Placebokontrollgruppen in Arzneimittelstudien |
| title_fullStr | Die rechtliche Zulässigkeit von Placebokontrollgruppen in Arzneimittelstudien |
| title_full_unstemmed | Die rechtliche Zulässigkeit von Placebokontrollgruppen in Arzneimittelstudien |
| title_short | Die rechtliche Zulässigkeit von Placebokontrollgruppen in Arzneimittelstudien |
| title_sort | die rechtliche zulassigkeit von placebokontrollgruppen in arzneimittelstudien |
| topic | thema EDItEUR::L Law |
| topic_facet | thema EDItEUR::L Law |
| url | OCN: 1091435474 |
| work_keys_str_mv | AT friskefranziskab dierechtlichezulassigkeitvonplacebokontrollgruppeninarzneimittelstudien |